CSIMarket Company Name, Ticker, Industry, else..


Alto Neuroscience Inc   (NYSE: ANRO)
Other Ticker:  
 


 

Alto Neuroscience Inc

ANRO's Financial Statements and Analysis



Alto Neuroscience Inc narrowed forth quarter of 2024 net loss per share of $-0.52 compare to net loss per share of $-2.50 recorded in the same quarter a year ago and improved compare to net loss per share of $-0.62 realized in previous quarter.


forth quarter of 2024
Earnings Per Share Revenues
$ -0.52 $  0 Mill
$+1.98     Unch.    



Alto Neuroscience Inc 's Revenue fell by 0 % in forth quarter of 2024 (Dec 31 2024) year on year, to $0 million and declined by sequentially.


Alto Neuroscience Inc is

More on ANRO's Income Statement



Alto Neuroscience Inc in the forth quarter of 2024 recorded net loss of $-15.201 million, an improvement compare to net loss of $-61.431 million in 2024 a year ago.

Sequentially net loss narrowed from net loss of $-16.783 million realized in previous quarter.

More on ANRO's Growth

Alto Neuroscience Inc Inventories
In Dec 31 2024 company's net cash and cash equivalents decreased by $-13 million, capital expenditures grew by -2.075-75.61%, to $-1 millions compare to same quarter a year ago

More on ANRO's Cash flow Statement


Alto Neuroscience Inc does not pay out common stock dividend.

In trailing twelve-month period Alto Neuroscience Inc payed $ -1.93 cash per share, on a free-cash flow basis .

Book value grew by 0.68 % sequentially to $6.16 per share.
Tangible Book value grew to $ 6.16 per share from $ 6.12.

Company repurchased 2.39 million shares or 8.85 % in Dec 31 2024.


• More on ANRO's Dividends

 Market Capitalization (Millions) 58
 Shares Outstanding (Millions) 25
 Total Debt (Millions $) 12
 Revenue (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -61
 Cash Flow (TTM) (Millions $) 86
 Capital Exp. (TTM) (Millions $) -2
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ -




Alto Neuroscience Inc does not pay out common stock dividend.

In trailing twelve-month period Alto Neuroscience Inc had negative $ -1.93 cash flow per share, on a free-cash flow basis .

Book value grew by 0.68 % sequentially to $6.16 per share.
Tangible Book value grew to $ 6.16 per share from $ 6.12.

Company repurchased 2.39 million shares or 8.85 % in Dec 31 2024.


• More on ANRO's Balance Sheets

 Market Capitalization (Millions) 58
 Shares Outstanding (Millions) 25
 Total Debt (Millions $) 12
 Revenue (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -61
 Cash Flow (TTM) (Millions $) 86
 Capital Exp. (TTM) (Millions $) -2
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ -
   


  News about Alto Neuroscience Inc Earnings